查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1614415

氟二酮市场：按纯度、应用和最终用户 - 2025-2030 年全球预测

Fluindione Market by Purity (95%, >= 98%), Application (Anticoagulating Treatment, Permanent Atrial Fibrillation, Pulmonary Embolism), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年氟二酮市值为9.199亿美元，预计到2024年将达到9.7151亿美元，复合年增长率为5.69%，到2030年将达到13.5551亿美元。

Fluindione 是一种抗凝血药物，主要用于预防和治疗深层静脉栓塞症和肺动脉栓塞等疾病，降低血栓风险。这项需求源自于由于世界老化导致心血管和血栓症相关疾病日益流行，从而产生了对抗凝血治疗的巨大需求。主要应用在医疗机构、医院和临床环境中，抗凝血治疗的准确性受到严格控制。最终用途包括有中风风险的患者、接受手术的患者以及需要有效和安全的管理通讯协定的患有血栓相关疾病的患者。

主要市场统计
基准年[2023] 9.199 亿美元
预计年份 [2024] 97151万美元
预测年份 [2030] 1,355.51 百万美元
复合年增长率（%） 5.69%

随着预防保健意识的提高、药物配方的进步以及专注于提高疗效和减少副作用的临床试验数量的增加，氟二酮市场正在形成。关键的成长要素包括不断发展的医疗基础设施、增加的研发投资以及加强抗凝血治疗框架的有利政府政策。在医疗保健创新和有利的人口结构推动下，新兴市场存在潜在的成长机会。透过策略伙伴关係和创新，公司可以开拓开拓的市场，扩大治疗适应症，并改善给药方案以获得更好的安全性。

然而，严格的监管核准、副作用管理和新型抗凝血剂的竞争等挑战可能会阻碍市场成长。此外，不良药物交互作用的风险限制了其广泛应用，特别是在老年人常见的多重用药场景。

创新可能集中在开发新的给药方法、精确剂量演算法和病患监测技术，以确保有效性和安全性。用于个人化医疗和即时剂量调整的人工智慧驱动的自动化系统是有前途的领域。市场是动态的，需要持续研究以适应监管变化、技术进步和患者人口统计的变化。为了实现永续成长，研究市场中的公司需要保持研究突破，专注于以患者为中心的创新，并建立策略伙伴关係以提高竞争力。

市场动态：揭示快速发展的完整 Indion 市场的关键市场洞察

供给和需求的动态相互作用正在改变整个印度市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 需要抗凝血治疗的疾病增加
    • 改善并扩大全球医疗保健基础设施
  • 市场限制因素
    • 对副作用和与其他药物相互作用的担忧
  • 市场机会
    • 全球正在开发新的药物输送系统
    • 氟喹酮新治疗应用的研究
  • 市场挑战
    • 严格的药品核准监理流程

波特五力：驾驭全英吉安市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解整个印度酮市场的外部影响

外部宏观环境因素在塑造 Full Indion 市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解整个印度市场的竞争状况

对 Full Indion 市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵 Full Indion 市场供应商绩效评估

FPNV 定位矩阵是评估 Full Indion 市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

战略分析和建议描绘了在全印度市场的成功之路

对于想要加强在全球市场的影响力的公司来说，对 Full Indion 市场进行策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 需要抗凝血治疗的疾病增加
      • 改善并扩大全球医疗保健基础设施
    • 抑制因素
      • 对副作用和与其他药物相互作用的担忧
    • 机会
      • 世界各地正在开发新的药物输送系统
      • 氟二酮其他治疗应用的研究
    • 任务
      • 严格的药品核准监理流程
  • 市场区隔分析
    • 纯度：为了满足活性药物成分 (API) 的严格要求，98% 或更高的纯度现在是全茚二酮的首要任务。
    • 应用：扩大氟二酮在抗凝血治疗的应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 完全的印度酮市场纯净度

  • 95%
  • >=98%

第七章完整的印度酮市场：依应用分类

  • 抗凝血治疗
  • 持续性心房颤动
  • 肺动脉栓塞
  • 静脉血栓症

第八章完整的印度酮市场：按最终用户分类

  • 医院/诊所
  • 长期照护设施

第九章 南北美洲完整的印度酮市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太全印度市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章 欧洲、中东和非洲的完整Indion市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Helicomer 获得 NIH 200 万美元津贴用于抗凝血药物开发
  • 战略分析和建议

公司名单

  • 1PlusChem LLC
  • Angene
  • Cayman Chemical Company
  • Clearsynth
  • DC Chemicals
  • Henan Bon Industrial Co.,Ltd.
  • Manus Aktteva Biopharma LLP
  • Merck KGaA
  • Prime Pharmaceuticals Pvt. Ltd.
  • Shodhana Laboratories Pvt. Ltd.
  • TargetMol Chemicals Inc.
  • TEBU-BIO LIMITED
Product Code: MRR-757B1C9CB035

The Fluindione Market was valued at USD 919.90 million in 2023, expected to reach USD 971.51 million in 2024, and is projected to grow at a CAGR of 5.69%, to USD 1,355.51 million by 2030.

Fluindione is an anticoagulant medication primarily used for preventing and treating conditions such as deep vein thrombosis and pulmonary embolism by reducing the risk of blood clots. Its necessity stems from the rising prevalence of cardiovascular diseases and thrombosis-related conditions, amplified by aging populations globally, creating a substantial demand for anticoagulant therapies. Its primary application is within healthcare institutions, hospitals, and clinical settings, where precision in anticoagulant therapy is critically managed. The end-use scope extends to patients at risk of stroke, those undergoing surgeries, or individuals with clot-related disorders necessitating effective and safe management protocols.

KEY MARKET STATISTICS
Base Year [2023] USD 919.90 million
Estimated Year [2024] USD 971.51 million
Forecast Year [2030] USD 1,355.51 million
CAGR (%) 5.69%

The market for Fluindione is shaped by increasing awareness about preventive healthcare, advancements in drug formulations, and a rising number of clinical trials focused on enhancing efficacy and reducing side effects. Key growth factors include evolving healthcare infrastructure, increasing investments in research & development, and favorable government policies fortifying anticoagulation treatment frameworks. Opportunities present in emerging markets driven by healthcare innovations and favorable demography can unlock potential growth avenues. Companies could explore untapped markets, expand therapeutic indications, or refine dosage regimens for better safety profiles through strategic partnerships and innovations.

However, challenges such as stringent regulatory approvals, side effects management, and competition from newer anticoagulants could hinder market growth. Moreover, the risk of adverse drug interactions, especially in polypharmacy scenarios common among the elderly, limits its expansive application.

Innovation could focus on developing novel delivery methods, precision dosing algorithms, or enhanced patient monitoring technologies that ensure efficacy and safety. Automated systems leveraging AI for personalized medicine and real-time dose adjustments represent promising areas. The market is dynamic, with continuous research required to adapt to regulatory changes, technological advancements, and shifts in patient demographics. For sustainable growth, companies in the Fluindione market should stay abreast of research breakthroughs, focus on patient-centric innovations, and establish strategic partnerships to enhance their competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fluindione Market

The Fluindione Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising cases of conditions requiring anticoagulation therapy
    • Improvements and expansions in the global healthcare infrastructure
  • Market Restraints
    • Concerns related to adverse effects and interactions with other medications
  • Market Opportunities
    • Ongoing development of novel drug delivery systems globally
    • Research into additional therapeutic applications of fluindione
  • Market Challenges
    • Stringent regulatory processes for drug approval

Porter's Five Forces: A Strategic Tool for Navigating the Fluindione Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fluindione Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fluindione Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fluindione Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fluindione Market

A detailed market share analysis in the Fluindione Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fluindione Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fluindione Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fluindione Market

A strategic analysis of the Fluindione Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fluindione Market, highlighting leading vendors and their innovative profiles. These include 1PlusChem LLC, Angene, Cayman Chemical Company, Clearsynth, DC Chemicals, Henan Bon Industrial Co.,Ltd., Manus Aktteva Biopharma LLP, Merck KGaA, Prime Pharmaceuticals Pvt. Ltd., Shodhana Laboratories Pvt. Ltd., TargetMol Chemicals Inc., and TEBU-BIO LIMITED.

Market Segmentation & Coverage

This research report categorizes the Fluindione Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Purity, market is studied across 95% and >= 98%.
  • Based on Application, market is studied across Anticoagulating Treatment, Permanent Atrial Fibrillation, Pulmonary Embolism, and Venous Thrombosis.
  • Based on End-User, market is studied across Hospitals & Clinics and Long-Term Care Facilities.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising cases of conditions requiring anticoagulation therapy
      • 5.1.1.2. Improvements and expansions in the global healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns related to adverse effects and interactions with other medications
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing development of novel drug delivery systems globally
      • 5.1.3.2. Research into additional therapeutic applications of fluindione
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory processes for drug approval
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Purity: Increasing preference for >=98% purity in fluindione for meeting stringent requirements for active pharmaceutical ingredients (APIs)
    • 5.2.2. Application: Expanding application of fluindione for anticoagulating treatment
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fluindione Market, by Purity

  • 6.1. Introduction
  • 6.2. 95%
  • 6.3. >= 98%

7. Fluindione Market, by Application

  • 7.1. Introduction
  • 7.2. Anticoagulating Treatment
  • 7.3. Permanent Atrial Fibrillation
  • 7.4. Pulmonary Embolism
  • 7.5. Venous Thrombosis

8. Fluindione Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
  • 8.3. Long-Term Care Facilities

9. Americas Fluindione Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Fluindione Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Fluindione Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Helixomer awarded $2M NIH grant for anticoagulant development
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 1PlusChem LLC
  • 2. Angene
  • 3. Cayman Chemical Company
  • 4. Clearsynth
  • 5. DC Chemicals
  • 6. Henan Bon Industrial Co.,Ltd.
  • 7. Manus Aktteva Biopharma LLP
  • 8. Merck KGaA
  • 9. Prime Pharmaceuticals Pvt. Ltd.
  • 10. Shodhana Laboratories Pvt. Ltd.
  • 11. TargetMol Chemicals Inc.
  • 12. TEBU-BIO LIMITED

LIST OF FIGURES

  • FIGURE 1. FLUINDIONE MARKET RESEARCH PROCESS
  • FIGURE 2. FLUINDIONE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FLUINDIONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FLUINDIONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FLUINDIONE MARKET SIZE, BY PURITY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FLUINDIONE MARKET SIZE, BY PURITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FLUINDIONE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FLUINDIONE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FLUINDIONE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FLUINDIONE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES FLUINDIONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES FLUINDIONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. FLUINDIONE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. FLUINDIONE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FLUINDIONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FLUINDIONE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FLUINDIONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FLUINDIONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FLUINDIONE MARKET DYNAMICS
  • TABLE 7. GLOBAL FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FLUINDIONE MARKET SIZE, BY 95%, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FLUINDIONE MARKET SIZE, BY >= 98%, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FLUINDIONE MARKET SIZE, BY ANTICOAGULATING TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FLUINDIONE MARKET SIZE, BY PERMANENT ATRIAL FIBRILLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FLUINDIONE MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FLUINDIONE MARKET SIZE, BY VENOUS THROMBOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FLUINDIONE MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FLUINDIONE MARKET SIZE, BY LONG-TERM CARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS FLUINDIONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES FLUINDIONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC FLUINDIONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA FLUINDIONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM FLUINDIONE MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM FLUINDIONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM FLUINDIONE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FLUINDIONE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. FLUINDIONE MARKET, FPNV POSITIONING MATRIX, 2023